Back to User profile » Dr Muye Xia
Papers published by Dr Muye Xia:
Soluble Programmed Cell Death-1: A Potential Predictor of HBsAg Loss in Pediatric Patients with Chronic Hepatitis B Undergoing Peginterferon Therapy
Yang G, Gan Y, Xia M, Fu Q, Zhang M, Luo K, Wang Z
ImmunoTargets and Therapy 2025, 14:1223-1231
Published Date: 4 November 2025
Soluble Programmed Cell Death-1 is a Novel Predictor of HBsAg Loss in Chronic Hepatitis B Patients When Long-Term Nucleos(t)ide Analog Treatment is Discontinued
Liao G, Liu Z, Xia M, Chen H, Wu H, Li B, Yu T, Cai S, Zhang X, Peng J
Infection and Drug Resistance 2022, 15:2347-2357
Published Date: 29 April 2022
aMAP Score as a Predictor for Long-Term Outcomes in Patients with HBV-Related Acute-on-Chronic Liver Failure
Sun Y, Li Z, Liao G, Xia M, Xu X, Cai S, Peng J
International Journal of General Medicine 2022, 15:407-415
Published Date: 10 January 2022
Hepatitis B Core-Related Antigen is a Biomarker for off-Treatment Relapse After Long-Term Nucleos(t)ide Analog Therapy in Patients with Chronic Hepatitis B
Liao G, Ding X, Xia M, Wu Y, Chen H, Fan R, Zhang X, Cai S, Peng J
International Journal of General Medicine 2021, 14:4967-4976
Published Date: 28 August 2021
Serum Hepatitis B Virus RNA Levels Predict HBeAg Seroconversion and Virological Response in Chronic Hepatitis B Patients with High Viral Load Treated with Nucleos(t)ide Analog
Ji X, Xia M, Zhou B, Liu S, Liao G, Cai S, Zhang X, Peng J
Infection and Drug Resistance 2020, 13:1881-1888
Published Date: 22 June 2020